These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 34174872

  • 1. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X, He Y, Shao Y, Hang B, Xu Z, Chu M.
    Pediatr Rheumatol Online J; 2021 Jun 26; 19(1):96. PubMed ID: 34174872
    [Abstract] [Full Text] [Related]

  • 2. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y, Wang XM, Liu YL, Shi K, Yang YF, Guo YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec 26; 14(12):938-41. PubMed ID: 23234782
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J, Jiang H, Lu M.
    Arch Argent Pediatr; 2020 Oct 26; 118(5):327-331. PubMed ID: 32924395
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
    Eur J Pediatr; 2023 Oct 26; 182(10):4399-4406. PubMed ID: 37480545
    [Abstract] [Full Text] [Related]

  • 5. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Oct 26; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 26; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 7. [Predictive indicators and risk model construction for coronary artery lesions in Kawasaki disease children over 5 years old].
    Zhang H, Zhang Y.
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 May 15; 26(5):461-468. PubMed ID: 38802905
    [Abstract] [Full Text] [Related]

  • 8. Association between maternal age and outcomes in Kawasaki disease patients.
    Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
    Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
    [Abstract] [Full Text] [Related]

  • 9. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 10. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 27; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 11. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 May 27; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

  • 12. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z, Weng F, Li C, Shi H, Tang Z, Qiu H, He Y, Wu R, Chu M.
    BMC Pediatr; 2018 Feb 21; 18(1):76. PubMed ID: 29466965
    [Abstract] [Full Text] [Related]

  • 13. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 21; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 14. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Oct 21; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 15. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 21; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 16. A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease.
    Wei M, Huang M, Chen S, Huang G, Huang M, Qiu D, Guo Z, Jiang J, Zhou X, Yu Q, Guo Y, Fu L, Gao W, Li F.
    Pediatr Cardiol; 2015 Aug 21; 36(6):1166-72. PubMed ID: 25812827
    [Abstract] [Full Text] [Related]

  • 17. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 21; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 18. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ, Kim WY, Park SM, Lee JH, Shin HJ, Jang GY, Ha KS.
    Medicina (Kaunas); 2020 Sep 11; 56(9):. PubMed ID: 32932823
    [Abstract] [Full Text] [Related]

  • 19. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Sep 11; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 20. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, Liu F.
    J Epidemiol; 2020 Oct 05; 30(10):429-435. PubMed ID: 31548437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.